sprout tirzepatide cost Home ✨ 𝗠𝗔𝗝𝗢𝗥 𝗨𝗣𝗗𝗔𝗧𝗘: 𝗭𝗘𝗣𝗕𝗢𝗨𝗡𝗗 (𝗧𝗜𝗥𝗭𝗘𝗣𝗔𝗧𝗜𝗗𝗘)

For type 2 diabetes management , NICE guidance (NG28) recommends GLP-1 agonists as second- or third-line therapy when metformin and other oral agents provide inadequate glycaemic control, or as an alternative to insulin in appropriate patients

If youre ready for a more personalized next step, the Health Quiz can help guide your routine

References WHO | Cardiovascular diseases (CVDs)

Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al

Dont Forget Your PBM One of the biggest mistakes employers make is focusing only on whether to cover GLP-1 medications while overlooking their Pharmacy Benefit Manager (PBM)

Tier 5: Renew Elite This includes all the offerings in Renew Premium with our additional Emsculpt NEO Discounted Package + 2 Free Emtone or Emsella treatments